S81541 |
K03861 |
源叶(MedMol) | ≥98%(HPLC) |
- 提示:详情请下载说明书。
- 产品描述: AUZ 454 (K03861) is a type II CDK2 inhibitor with Kd of 8.2 nM. AUZ 454 (K03861) inhibits CDK2 activity by competing with binding of activating cyclins
- 靶点: CDK2(C118L/A144C):9.7 nM (Kd);CDK2(A144C):15.4 nM (Kd);CDK2(C118L):18.6 nM (Kd);CDK2(WT):50 nM (Kd);CDK2(C118L/A144C-Cyclin B):134.1 nM (Kd);CDK
- 体外研究:
AUZ 454 (K03861) (10-20 μM; 1, 2, 3, and 4 days) has a inhibitory effect on Caki-1 and ACHN cells with WTAP overexpression by CCK8 assays. AUZ 454 (K03861) (10 μM; 24 hours) decreases the colony fold in Caki-1 and ACHN cells through a CDK2-dependent mechanism. Cell Proliferation Assay Cell Line: Caki-1 and ACHN cells Concentration: 10 μM; 20 μM Incubation Time: 1, 2, 3, and 4 days Result: Inhibited cell proliferation in a CDK2-dependent manner.
- 参考文献:
1. Alexander LT et al. Type II Inhibitors Targeting CDK2. ACS Chem Biol. 2015 Sep 18;10(9):2116-25. 2. Tang J,et al. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.J Exp Clin Cancer Res. 2018 Feb 27;37(1):40.
- 溶解性: soluble in DMSO
- 保存条件: -20℃
- 配置溶液浓度参考:
1mg 5mg 10mg 1 mM 1.994 ml 9.97 ml 19.94 ml 5 mM 0.399 ml 1.994 ml 3.988 ml 10 mM 0.199 ml 0.997 ml 1.994 ml 50 mM 0.04 ml 0.199 ml 0.399 ml
- 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)